Skip to content
CNS Clinical Research

Missouri

CNS clinical trials in Missouri

95 CNS studies are recruiting participants at sites in 15 cities across Missouri as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Missouri city with a recruiting study

By research area: Depression (30), Parkinson's Disease (17), Multiple Sclerosis (14), Schizophrenia (11), Migraine (10), Epilepsy (8), Bipolar Disorder (3), ADHD (2).

St Louis (69), Saint Charles (12), Kansas City (11), Springfield (6), City of Saint Peters (5), O'Fallon (5), Columbia (4), Chesterfield (2), Hazelwood (2), Ballwin (1), Creve Coeur (1), Lee's Summit (1), Osage Beach (1), Saint Joseph (1), Weldon Spring (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Missouri

Basic details from each study's public record (the 12 most recently updated of 95). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    O'Fallon · Saint Charles
    Registry record
    NCT07226661 · updated
  2. A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Seaport Therapeutics
    Recruiting in
    St Louis
    Registry record
    NCT07065240 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Missouri on ClinicalTrials.gov.

Bipolar disorder: recently updated in Missouri

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    St Louis
    Registry record
    NCT06951711 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Missouri on ClinicalTrials.gov.

Parkinson's disease: recently updated in Missouri

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Springfield · St Louis
    Registry record
    NCT06989112 · updated
  2. A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Kansas City · Springfield
    Registry record
    NCT06345729 · updated
  3. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    St Louis
    Registry record
    NCT06952504 · updated
  4. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Kansas City · St Louis
    Registry record
    NCT06966700 · updated
  5. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    St Louis
    Registry record
    NCT06996652 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Missouri on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Missouri

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    City of Saint Peters · Creve Coeur · Kansas City · and 2 more U.S. locations
    Registry record
    NCT03816345 · updated
  2. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    St Louis
    Registry record
    NCT07299019 · updated
  3. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    St Louis
    Registry record
    NCT07067463 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Missouri on ClinicalTrials.gov.

Migraine: recently updated in Missouri

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    St Louis
    Registry record
    NCT06972056 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Missouri on ClinicalTrials.gov.

Ask about studies in Missouri

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call